Taken together, this emphasizes the importance in timely initiation of GLP-1RA, targeting the primary preventive population with overweight/obesity, prior to the manifestation of T2DM and development of ASCVD [92,93,94,95]
The decline in NAD + levels therefore results in impaired metabolism and mitochondrial function via SIRTs and PGC-1
GLP-1s for Cancer Prevention Because population studies are observational, they cant prove that GLP-1s lower cancer risk
Resistance training and higher dietary protein intake are strongly recommended to counteract sarcopenic effects
Dr Adam Abbs MBBS FRCGP PGCCE FHEA Dr Adam Abbs is an NHS-trained GP with a keen focus on digital health, AI in healthcare, and personalised medicine, including weight loss